GT Metabolic Solutions, Inc.

GT Metabolic Solutions is a medical device company specializing in magnetic compression anastomosis technologies for minimally invasive bariatric and metabolic surgery. Founded in May 2020 by Dr. Michel Gagner and Thierry Thaure, the company holds a portfolio of over 17 patents focused on advancing surgical techniques. The flagship MagDI™ System represents an innovative incisionless, sutureless, and staple-free surgical approach using magnetic technology to create anastomosis, particularly for side-to-side duodeno-ileal procedures. The system received FDA De Novo marketing authorization in July 2024, with subsequent 510(k) clearances for second-generation magnets in 2024 and 2025. Clinical evidence demonstrates the MagDI™ System enables durable weight loss and improved glycemic control in obese patients with or without type 2 diabetes. The technology eliminates foreign material implantation, supporting natural tissue healing and enabling outpatient surgical delivery. GT Metabolic is actively advancing clinical trials in North America and Europe, positioning magnetic surgery as a next-generation frontier in minimally invasive bariatric and metabolic procedures.